V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006447 | 320005654 | 1.8 | 106.2 | Palliative (P) | 2017-08-19 | 2017-08-19 | Carboplatin + Liposomal Doxorubicin | N | Y | 320016881 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006448 | 320003622 | 1.86 | null | Palliative (P) | 2017-08-16 | 2018-02-27 | Cisplatin +Fluorouracil (3 wk) | N | N | 320017011 | CISPLATIN + FLUOROURACIL |
| 320006449 | 320003625 | 1.55 | 58.1 | Palliative (P) | 2018-03-04 | 2018-03-12 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320017087 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006450 | 320003626 | 1.65 | 68.4 | Palliative (P) | 2015-01-21 | 2015-01-21 | Carboplatin + Liposomal Doxorubicin | N | N | 320017094 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006451 | 320003629 | 1.58 | 70 | Adjuvant (A) | 2016-06-07 | 2016-07-04 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320017120 | CISPLATIN + RT |
| 320006452 | 320003631 | 1.64 | 63.6 | Neo-adjuvant (N) | null | 2014-11-07 | CISPLATIN + FLUOROURACIL | 02 | N | 320017125 | CISPLATIN + FLUOROURACIL |
| 320006453 | 320003635 | 1.65 | 67.6 | Palliative (P) | 2017-02-23 | 2017-03-02 | GemCarbo Days 1+8 | N | Y | 320017164 | GEMCARBO |
| 320006454 | 320006626 | null | 71.1 | Palliative (P) | 2016-07-12 | 2016-07-13 | CARBOPLATIN + GEMCITABINE | 2 | N | 320017178 | GEMCARBO |
| 320006455 | 320003636 | 1.87 | 82.3 | null | null | 2018-01-07 | Liposomal Doxorubicin (Caelyx) | N | N | 320017180 | LIPOSOMAL DOXORUBICIN |
| 320006456 | 320006627 | 1.6 | 93.6 | Curative (C) | 2016-07-31 | 2016-07-31 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320017217 | CISPLATIN + RT |
| 320006457 | 320003639 | 1.74 | 24.2 | Curative (C) | 2015-12-03 | 2016-03-27 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320017230 | CISPLATIN + RT |
| 320006458 | 320003642 | 0 | 88.5 | Palliative (P) | 2017-10-06 | 2017-10-11 | GemCarbo Days 1+8 | N | N | 320017245 | GEMCARBO |
| 320006459 | 320003644 | 1.61 | null | Palliative (P) | 2015-11-18 | 2015-11-22 | Trial Unspecified | 02 | null | 320017254 | TRIAL |
| 320006460 | 320003650 | 1.65 | null | Palliative (P) | 2016-10-02 | 2016-10-17 | CETUXIMAB | 02 | N | 320017319 | CETUXIMAB |
| 320006461 | 320003658 | 1.6 | 80.75 | Palliative (P) | 2017-03-11 | 2017-03-28 | Liposomal Doxorubicin 40mg/m2 | N | N | 320017403 | LIPOSOMAL DOXORUBICIN |
| 320006462 | 320003662 | 1.89 | 95 | Palliative (P) | 2013-12-14 | 2015-05-10 | GemCarbo Days 1+8 | N | N | 320017420 | GEMCARBO |
| 320006463 | 320003664 | 1.85 | 77.4 | Palliative (P) | 2016-03-21 | 2016-03-21 | GemCarbo Days 1+8 | N | null | 320017423 | GEMCARBO |
| 320006464 | 320003665 | null | 67.5 | Palliative (P) | 2015-04-20 | 2015-05-12 | Carboplatin + Liposomal Doxorubicin | null | null | 320017443 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006465 | 320003667 | null | 79.6 | Curative (C) | 2017-08-01 | 2017-09-01 | Cisplatin | Y | N | 320017455 | CISPLATIN |
| 320006466 | 320003667 | 1.24 | 88.2 | Curative (C) | 2019-03-18 | 2019-04-11 | Cisplatin + Radiotherapy | null | null | 320017455 | CISPLATIN + RT |
| 320006467 | 320005675 | 1.58 | 54 | Palliative (P) | 2016-03-15 | 2016-03-15 | Carboplatin + Liposomal Doxorubicin | N | N | 320017480 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006468 | 320003669 | 1.68 | 71.9 | Palliative (P) | 2016-12-07 | 2017-07-10 | CARBOPLATIN + GEMCITABINE | N | N | 320017492 | GEMCARBO |
| 320006469 | 320003671 | 1.69 | 81 | Curative (C) | 2016-05-07 | 2016-07-04 | CISPLATIN + FLUOROURACIL | 02 | N | 320017521 | CISPLATIN + FLUOROURACIL |
| 320006470 | 320003675 | 1.54 | 79.7 | Palliative (P) | 2017-03-24 | 2017-04-02 | Carboplatin + Liposomal Doxorubicin | null | null | 320017559 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006471 | 320003677 | 1.5 | 75.9 | Palliative (P) | 2015-05-22 | 2015-06-21 | CARBOPLATIN + GEMCITABINE | Y | N | 320017615 | GEMCARBO |
| 320006472 | 320005683 | 1.56 | 44 | Palliative (P) | 2017-01-31 | 2017-03-02 | GEMCARBO | N | N | 320017640 | GEMCARBO |
| 320006473 | 320003680 | null | 81 | Adjuvant (A) | 2017-04-01 | 2017-04-06 | CARBOPLATIN + GEMCITABINE | 2 | N | 320017657 | GEMCARBO |
| 320006474 | 320003685 | 1.57 | 80.6 | Curative (C) | 2016-03-07 | 2016-04-10 | Trial Unspecified | N | N | 320017683 | TRIAL |
| 320006476 | 320003691 | 1.54 | 75.3 | Disease modification (D) | 2017-06-23 | 2017-07-15 | Cetuximab 7 day (Cycle 1) | N | N | 320017733 | CETUXIMAB |
| 320006477 | 320003697 | 0 | 61.4 | Palliative (P) | null | 2018-07-06 | CETUXIMAB | null | Y | 320017787 | CETUXIMAB |
| 320006478 | 320003701 | 1.31 | 72.9 | Palliative (P) | 2016-04-25 | 2016-04-25 | Trial Unspecified | 2 | N | 320017790 | TRIAL |
| 320006479 | 320003703 | 1.73 | 72.9 | Palliative (P) | 2018-06-18 | 2018-06-18 | GEMCARBO | 02 | N | 320017913 | GEMCARBO |
| 320006480 | 320003706 | 1.67 | 96 | Palliative (P) | 2019-06-27 | 2019-06-27 | CISPLATIN + FLUOROURACIL | N | Y | 320017944 | CISPLATIN + FLUOROURACIL |
| 320006481 | 320003709 | 1.63 | 63.1 | Palliative (P) | 2017-06-12 | 2017-06-13 | Liposomal Doxorubicin 40mg/m2 | 02 | Y | 320017969 | LIPOSOMAL DOXORUBICIN |
| 320006482 | 320003709 | 1.64 | 54.5 | Curative (C) | 2017-01-15 | 2018-12-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320017969 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006483 | 320003710 | 1.75 | 74.4 | Adjuvant (A) | 2015-09-26 | 2015-10-10 | Cisplatin + Radiotherapy | 02 | N | 320018017 | CISPLATIN + RT |
| 320006484 | 320003712 | 1.88 | 103 | Curative (C) | 2014-07-22 | 2014-08-20 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 320018047 | CISPLATIN + RT |
| 320006485 | 320003715 | 1.52 | null | null | 2018-02-15 | 2018-05-15 | GemCarbo Days 1+8 | 02 | N | 320018067 | GEMCARBO |
| 320006486 | 320006643 | 1.75 | null | Palliative (P) | 2018-01-01 | 2018-01-01 | Carboplatin + Liposomal Doxorubicin | N | N | 320018100 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006487 | 320003720 | 1.78 | 95.9 | Palliative (P) | 2015-04-13 | 2015-04-20 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 320018148 | LIPOSOMAL DOXORUBICIN |
| 320006488 | 320003723 | 1.7 | 59 | Palliative (P) | 2017-03-21 | 2017-03-21 | CISPLATIN + FLUOROURACIL | N | N | 320018237 | CISPLATIN + FLUOROURACIL |
| 320006489 | 320005701 | 1.75 | null | Palliative (P) | 2019-01-20 | 2019-01-20 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 320018257 | LIPOSOMAL DOXORUBICIN |
| 320006490 | 320003727 | 1.7 | 69 | Curative (C) | 2016-08-11 | 2016-10-20 | CISPLATIN + RT | N | N | 320018285 | CISPLATIN + RT |
| 320006491 | 320006645 | 1.56 | null | Palliative (P) | 2018-09-16 | 2018-10-01 | Cisplatin + Modified de Gramont | N | Y | 320018383 | CISPLATIN + FLUOROURACIL |
| 320006492 | 320007299 | 1.64 | 75.55 | null | 2013-08-14 | 2014-04-13 | Cisplatin | 2 | N | 320018384 | CISPLATIN |
| 320006493 | 320003733 | null | 16.3 | Neo-adjuvant (N) | 2015-05-21 | 2015-07-03 | CISPLATIN + GEMCITABINE | N | N | 320018416 | CETUXIMAB + RT |
| 320006494 | 320005705 | 1.59 | 105.3 | Palliative (P) | 2014-01-19 | 2015-10-26 | PEMBROLIZUMAB | 02 | N | 320018420 | NIVOLUMAB |
| 320006496 | 320003736 | 1.76 | 65.1 | Adjuvant (A) | 2017-07-18 | 2017-08-17 | ICON8 TRIAL | 02 | N | 320018494 | PCV |
| 320006497 | 320003738 | 1.69 | 60 | Adjuvant (A) | 2017-03-10 | 2017-06-07 | GEMCITABINE | N | N | 320018500 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006498 | 320003741 | 1.68 | 63.6 | Palliative (P) | 2014-06-08 | 2014-06-08 | PEMBROLIZUMAB | 02 | null | 320018528 | GEMCITABINE |